Animal models of autism spectrum disorder (ASD): A synaptic-level approach to autistic-like behavior in mice

Experimental Animals

Volumn 62, Issue 2, 2013, Pages 71-78

  Shinoda, Yo ^a,b   Sadakata, Tetsushi ^b,c   Furuichi, Teiichi ^a,b,d  

^a TOKYO UNIVERSITY OF SCIENCE   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c GUNMA UNIVERSITY   (Japan)

^d RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

ASD; Autism; BDNF; CAPS2

Indexed keywords

NEUREXIN; NEUROLIGIN; SCAFFOLD PROTEIN; SHANK PROTEIN; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; AUTISM; CADPS2 GENE; CAPS2 GENE; DISEASE ASSOCIATION; DISEASE MODEL; GENE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC CODE; HEREDITY; KNOCKOUT MOUSE; MOUSE; NERVE CELL PLASTICITY; NEUREXIN GENE; NEUROLIGIN GENE; NEUROTRANSMISSION; NONHUMAN; PHENOTYPE; REVIEW; SHANK GENE; SYNAPSE;

ANIMALS; BEHAVIOR, ANIMAL; CALCIUM-BINDING PROTEINS; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CHILD, PRESCHOOL; DISEASE MODELS, ANIMAL; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INFANT; MICE; MICE, KNOCKOUT; MICE, MUTANT STRAINS; MUTATION; NERVE TISSUE PROTEINS; NEUROGENESIS; NEURONAL PLASTICITY; PHENOTYPE; SECRETORY VESICLES; SYNAPSES; SYNAPTIC TRANSMISSION;

ANIMALIA; MUS;

EID: 84876777521     PISSN: 13411357     EISSN: None     Source Type: Journal    
DOI: 10.1538/expanim.62.71     Document Type: Review

References (34)

1. A brahams, B.S. and Geschwind, D.H. 2008. Advances in autism genetics: on the threshold of a new neurobiology. Nat. Rev. Genet. 9: 341-355. [Medline] [CrossRef]
2. Bangash, M.A., Park, J.M., Melnikova, T., Wang, D., Jeon, S.K., Lee, D., Syeda, S., Kim, J., Kouser, M., Schwartz, J., Cui, Y., Zhao, X., Speed, H.E., Kee, S.E., Tu, J.C., Hu, J.H., Petralia, R.S., Linden, D.J., Powell, C.M., Savonenko, A., Xiao, B., and Worley, P.F. 2011. Enhanced polyubiquitination of Shank3 and NMDA receptor in a mouse model of autism. Cell 145: 758-772. [Medline] [CrossRef]
3. Berkel, S., Marshall, C.R., Weiss, B., Howe, J., Roeth, R., Moog, U., Endris, V., Roberts, W., Szatmari, P., Pinto, D., Bonin, M., Riess, A., Engels, H., Sprengel, R., Scherer, S.W., and Rappold, G.A. 2010. Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation. Nat. Genet. 42: 489-491. [Medline] [CrossRef]
4. Bill, B.R. and Geschwind, D.H. 2009. Genetic advances in autism: heterogeneity and convergence on shared pathways. Curr. Opin. Genet. Dev. 19: 271-278. [Medline] [CrossRef]
5. Bourgeron, T. 2009. A synaptic trek to autism. Curr. Opin. Neurobiol. 19: 231-234. [Medline] [CrossRef]
6. Buxbaum, J.D. 2009. Multiple rare variants in the etiology of autism spectrum disorders. Dialogues Clin. Neurosci. 11: 35-43. [Medline]
7. C hadman, K.K., Gong, S., Scattoni, M.L., Boltuck, S.E., Gandhy, S.U., Heintz, N., and Crawley, J.N. 2008. Minimal aberrant behavioral phenotypes of neuroligin-3 R451C knockin mice. Autism Res. 1: 147-158. [Medline] [Cross- Ref]
8. D urand, C.M., Betancur, C., Boeckers, T.M., Bockmann, J., Chaste, P., Fauchereau, F., Nygren, G., Rastam, M., Gillberg, I.C., Anckarsater, H., Sponheim, E., Goubran-Botros, H., Delorme, R., Chabane, N., Mouren-Simeoni, M.C., de Mas, P., Bieth, E., Roge, B., Heron, D., Burglen, L., Gillberg, C., Leboyer, M., and Bourgeron, T. 2007. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat. Genet. 39: 25-27. [Medline] [CrossRef]
9. Etherton, M., Foldy, C., Sharma, M., Tabuchi, K., Liu, X., Shamloo, M., Malenka, R.C., and Sudhof, T.C. 2011. Autism- linked neuroligin-3 R451C mutation differentially alters hippocampal and cortical synaptic function. Proc. Natl. Acad. Sci. U.S.A. 108: 13764-13769. [Medline] [CrossRef]
10. Etherton, M.R., Blaiss, C.A., Powell, C.M., and Sudhof, T.C. 2009. Mouse neurexin-1alpha deletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairments. Proc. Natl. Acad. Sci. U.S.A. 106: 17998-18003. [Medline] [CrossRef]
11. Etherton, M.R., Tabuchi, K., Sharma, M., Ko, J., and Sudhof, T.C. 2011. An autism-associated point mutation in the neu roligin cytoplasmic tail selectively impairs AMPA receptormediated synaptic transmission in hippocampus. EMBO J. 30: 2908-2919. [Medline] [CrossRef]
12. Feng, J., Schroer, R., Yan, J., Song, W., Yang, C., Bockholt, A., Cook, E.H. Jr., Skinner, C., Schwartz, C.E., and Sommer, S.S. 2006. High frequency of neurexin 1beta signal peptide structural variants in patients with autism. Neurosci. Lett. 409: 10-13. [Medline] [CrossRef]
13. Freitag, C.M. 2007. The genetics of autistic disorders and its clinical relevance: a review of the literature. Mol. Psychiatry 12: 2-22. [Medline] [CrossRef]
14. Gauthier, J., Siddiqui, T.J., Huashan, P., Yokomaku, D., Hamdan, F.F., Champagne, N., Lapointe, M., Spiegelman, D., Noreau, A., Lafreniere, R.G., Fathalli, F., Joober, R., Krebs, M.O., DeLisi, L.E., Mottron, L., Fombonne, E., Michaud, J.L., Drapeau, P., Carbonetto, S., Craig, A.M., and Rouleau, G.A. 2011. Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia. Hum. Genet. 130: 563-573. [Medline] [CrossRef]
15. H ung, A.Y., Futai, K., Sala, C., Valtschanoff, J.G., Ryu, J., Woodworth, M.A., Kidd, F.L., Sung, C.C., Miyakawa, T., Bear, M.F., Weinberg, R.J., and Sheng, M. 2008. Smaller dendritic spines, weaker synaptic transmission, but enhanced spatial learning in mice lacking Shank1. J. Neurosci. 28: 1697-1708. [Medline] [CrossRef]
16. Jamain, S., Quach, H., Betancur, C., Rastam, M., Colineaux, C., Gillberg, I.C., Soderstrom, H., Giros, B., Leboyer, M., Gillberg, C., and Bourgeron, T. 2003. Mutations of the Xlinked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat. Genet. 34: 27-29. [Medline] [CrossRef]
17. Laumonnier, F., Bonnet-Brilhault, F., Gomot, M., Blanc, R., David, A., Moizard, M.P., Raynaud, M., Ronce, N., Lemonnier, E., Calvas, P., Laudier, B., Chelly, J., Fryns, J.P., Ropers, H.H., Hamel, B.C., Andres, C., Barthelemy, C., Moraine, C., and Briault, S. 2004. X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. Am. J. Hum. Genet. 74: 552-557. [Medline] [CrossRef]
18. Missler, M., Zhang, W., Rohlmann, A., Kattenstroth, G., Hammer, R.E., Gottmann, K., and Sudhof, T.C. 2003. Alphaneurexins couple Ca2+ channels to synaptic vesicle exocytosis. Nature 423: 939-948. [Medline] [CrossRef]
19. N akatani, J., Tamada, K., Hatanaka, F., Ise, S., Ohta, H., Inoue, K., Tomonaga, S., Watanabe, Y., Chung, Y.J., Banerjee, R., Iwamoto, K., Kato, T., Okazawa, M., Yamauchi, K., Tanda, K., Takao, K., Miyakawa, T., Bradley, A., and Takumi, T. 2009. Abnormal behavior in a chromosome-engineered mouse model for human 15q11-13 duplication seen in autism. Cell 137: 1235-1246. [Medline] [CrossRef]
20. Persico, A.M. and Bourgeron, T. 2006. Searching for ways out of the autism maze: genetic, epigenetic and environmental clues. Trends Neurosci. 29: 349-358. [Medline] [CrossRef]
21. R adyushkin, K., Hammerschmidt, K., Boretius, S., Varoqueaux, F., El-Kordi, A., Ronnenberg, A., Winter, D., Frahm, J., Fischer, J., Brose, N., and Ehrenreich, H. 2009. Neuroligin-3-deficient mice: model of a monogenic heritable form of autism with an olfactory deficit. Genes Brain Behav. 8: 416-425. [Medline] [CrossRef]
22. Sadakata, T. and Furuichi, T. 2009. Developmentally regulated Ca2+-dependent activator protein for secretion 2 (CAPS2) is involved in BDNF secretion and is associated with autism susceptibility. Cerebellum 8: 312-322. [Medline] [Cross- Ref]
23. Sadakata, T., Itakura, M., Kozaki, S., Sekine, Y., Takahashi, M., and Furuichi, T. 2006. Differential distributions of the Ca2+ -dependent activator protein for secretion family proteins (CAPS2 and CAPS1) in the mouse brain. J. Comp. Neurol. 495: 735-753. [Medline] [CrossRef]
24. Sadakata, T., Kakegawa, W., Mizoguchi, A., Washida, M., Katoh-Semba, R., Shutoh, F., Okamoto, T., Nakashima, H., Kimura, K., Tanaka, M., Sekine, Y., Itohara, S., Yuzaki, M., Nagao, S., and Furuichi, T. 2007. Impaired cerebellar development and function in mice lacking CAPS2, a protein involved in neurotrophin release. J. Neurosci. 27: 2472-2482. [Medline] [CrossRef]
25. Sadakata, T., Mizoguchi, A., Sato, Y., Katoh-Semba, R., Fukuda, M., Mikoshiba, K., and Furuichi, T. 2004. The secretory granule-associated protein CAPS2 regulates neurotrophin release and cell survival. J. Neurosci. 24: 43-52. [Medline] [CrossRef]
26. Sadakata, T., Washida, M., Iwayama, Y., Shoji, S., Sato, Y., Ohkura, T., Katoh-Semba, R., Nakajima, M., Sekine, Y., Tanaka, M., Nakamura, K., Iwata, Y., Tsuchiya, K.J., Mori, N., Detera-Wadleigh, S.D., Ichikawa, H., Itohara, S., Yoshikawa, T., and Furuichi, T. 2007. Autistic-like phenotypes in Cadps2-knockout mice and aberrant CADPS2 splicing in autistic patients. J. Clin. Invest. 117: 931-943. [Medline] [CrossRef]
27. Schanen, N.C. 2006. Epigenetics of autism spectrum disorders. Hum. Mol. Genet. 15: R138-R150. [Medline] [Cross- Ref]
28. Shinoda, Y., Sadakata, T., Nakao, K., Katoh-Semba, R., Kinameri, E., Furuya, A., Yanagawa, Y., Hirase, H., and Furuichi, T. 2011. Calcium-dependent activator protein for secretion 2 (CAPS2) promotes BDNF secretion and is critical for the development of GABAergic interneuron network. Proc. Natl. Acad. Sci. U.S.A. 108: 373-378. [Medline] [CrossRef]
29. Szatmari, P., Paterson, A.D., Zwaigenbaum, L., Roberts, W., Brian, J., Liu, X.Q., Vincent, J.B., Skaug, J.L., Thompson, A.P., Senman, L., Feuk, L., Qian, C., Bryson, S.E., Jones, M.B., Marshall, C.R., Scherer, S.W., Vieland, V.J., Bartlett, C., Mangin, L.V., Goedken, R., Segre, A., Pericak-Vance, M.A., Cuccaro, M.L., Gilbert, J.R., Wright, H.H., Abramson, R.K., Betancur, C., Bourgeron, T., Gillberg, C., Leboyer, M., Buxbaum, J.D., Davis, K.L., Hollander, E., Silverman, J.M., Hallmayer, J., Lotspeich, L., Sutcliffe, J.S., Haines, J.L., Folstein, S.E., Piven, J., Wassink, T.H., Sheffield, V., Geschwind, D.H., Bucan, M., Brown, W.T., Cantor, R.M., Constantino, J.N., Gilliam, T.C., Herbert, M., Lajonchere, C., Ledbetter, D.H., Lese-Martin, C., Miller, J., Nelson, S., Samango-Sprouse, C.A., Spence, S., State, M., Tanzi, R.E., Coon, H., Dawson, G., Devlin, B., Estes, A., Flodman, P., Klei, L., McMahon, W.M., Minshew, N., Munson, J., Korvatska, E., Rodier, P.M., Schellenberg, G.D., Smith, M., Spence, M.A., Stodgell, C., Tepper, P.G., Wijsman, E.M., Yu, C.E., Roge, B., Mantoulan, C., Wittemeyer, K., Poustka, A., Felder, B., Klauck, S.M., Schuster, C., Poustka, F., Bolte, S., Feineis-Matthews, S., Herbrecht, E., Schmotzer, G., Tsiantis, J., Papanikolaou, K., Maestrini, E., Bacchelli, E., Blasi, F., Carone, S., Toma, C., Van Engeland, H., de Jonge, M., Kemner, C., Koop, F., Langemeijer, M., Hijmans, C., Staal, W.G., Baird, G., Bolton, P.F., Rutter, M.L., Weisblatt, E., Green, J., Aldred, C., Wilkinson, J.A., Pickles, A., Le Couteur, A., Berney, T., McConachie, H., Bailey, A.J., Francis, K., Honeyman, G., Hutchinson, A., Parr, J.R., Wallace, S., Monaco, A.P., Barnby, G., Kobayashi, K., Lamb, J.A., Sousa, I., Sykes, N., Cook, E.H., Guter, S.J., Leventhal, B.L., Salt, J., Lord, C., Corsello, C., Hus, V., Weeks, D.E., Volkmar, F., Tauber, M., Fombonne, E., Shih, A., and Meyer, K.J. 2007. Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat. Genet. 39: 319-328. [Medline] [CrossRef]
30. Tabuchi, K., Blundell, J., Etherton, M.R., Hammer, R.E., Liu, X., Powell, C.M., and Sudhof, T.C. 2007. A neuroligin- 3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 318: 71-76. [Medline] [CrossRef]
31. Yan, J., Noltner, K., Feng, J., Li, W., Schroer, R., Skinner, C., Zeng, W., Schwartz, C.E., and Sommer, S.S. 2008. Neurexin 1alpha structural variants associated with autism. Neurosci. Lett. 438: 368-370. [Medline] [CrossRef]
32. Yan, J., Oliveira, G., Coutinho, A., Yang, C., Feng, J., Katz, C., Sram, J., Bockholt, A., Jones, I.R., Craddock, N., Cook, E.H. Jr., Vicente, A., and Sommer, S.S. 2005. Analysis of the neuroligin 3 and 4 genes in autism and other neuropsychiatric patients. Mol. Psychiatry 10: 329-332. [Medline] [CrossRef]
33. Yang, M.S. and Gill, M. 2007. A review of gene linkage, association and expression studies in autism and an assessment of convergent evidence. Int. J. Dev. Neurosci. 25: 69-85. [Medline] [CrossRef]
34. Zhang, C., Milunsky, J.M., Newton, S., Ko, J., Zhao, G., Maher, T.A., Tager-Flusberg, H., Bolliger, M.F., Carter, A.S., Boucard, A.A., Powell, C.M., and Sudhof, T.C. 2009. A neuroligin- 4 missense mutation associated with autism impairs neuroligin-4 folding and endoplasmic reticulum export. J. Neurosci. 29: 10843-10854. [Medline] [CrossRef]